Forian Inc. reported its financial results for the first quarter of 2026, revealing a revenue of $6.85 million, a decrease of 2.9% from $7.06 million in the same period last year. The decline in revenue was primarily attributed to lower contributions from health science customers due to contract terminations, although this was partially offset by growth from new customers. The company's operating loss widened to $3.49 million compared to a loss of $1.39 million in the prior year, driven by increased costs of revenues and strategic review expenses.

Total costs and expenses for the quarter reached $10.34 million, up from $8.45 million in the previous year. The cost of revenues surged to $4.84 million, a significant increase from $3.13 million, largely due to higher information licensing and processing expenses. Research and development expenses also rose to $961,458, reflecting an increase in employee-related costs. Conversely, general and administrative expenses decreased to $2.45 million from $3.28 million, primarily due to lower stock compensation expenses.

In terms of operational metrics, Forian's cash and cash equivalents increased significantly to $30.95 million as of March 31, 2026, compared to $12.90 million at the end of 2025. The company reported a net loss of $3.36 million, or $0.11 per share, compared to a net loss of $1.13 million, or $0.04 per share, in the prior year. The weighted average shares outstanding for the quarter were approximately 31.15 million, slightly up from 31.12 million in the previous year.

Strategically, Forian has undergone significant organizational changes, including a redomiciliation from Delaware to Maryland, which was approved by shareholders in January 2026. Additionally, the company is in the process of a merger agreement with 2025 Acquisition Company, LLC, which involves a tender offer for its common stock at $2.17 per share. This merger is expected to enhance Forian's operational capabilities and market position.

Looking ahead, Forian anticipates continued challenges in revenue generation due to market conditions and customer dynamics. The company plans to focus on expanding its customer base and enhancing its product offerings to drive future growth. Management remains committed to improving operational efficiencies and addressing the material weakness identified in its internal controls over financial reporting.

About Forian Inc.

Forian Inc. provides data management, analytics, and information solutions to the healthcare, life sciences, and financial services industries. Leveraging large-scale, de-identified patient and market data, it offers subscription-based products to optimize clinical, operational, and commercial performance. Its proprietary data factory and analytics tools enable insights into patient journeys, treatment efficacy, and market dynamics, supporting evidence-based decision-making and advancing real-world evidence in a highly regulated, data-driven environment.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.